The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams.
The protective efficacy against Brucella ovis of the live vaccine Brucella abortus strain RB51 has been evaluated in rams using the attenuated B. melitensis strain Rev 1 as a reference vaccine. Sixteen Brucella-free rams, 6 months of age, were vaccinated subcutaneously with 4.18 x 10(10) c.f.u. RB51. Sixteen rams of the same condition and age were vaccinated subcutaneously the same day with 1.1 x 10(9) c.f.u. Rev 1. Fifteen similar rams were kept unvaccinated as controls. Six months after vaccination all rams were challenged with 3 x 10(9) c.f.u. B. ovis and slaughtered 8 weeks thereafter for bacteriological and pathological studies. The percentage of rams that were found infected was 68% (Rev 1), 100% (RB51) and 100% (controls). At necropsy, the percentage of organs found to be infected was significantly lower (p < 0.0005) in Rev 1-vaccinated (34%) than in RB51-vaccinated rams (74%) or controls (69%). In conclusion, the RB51 vaccine did not confer protective immunity against B. ovis in rams.
Jiménez de Bagüés
M P
MP
Dpt. Sanidad Animal, SIA/DGA, Zaragoza, Spain.
Barberán
M
M
Marín
C M
CM
Blasco
J M
JM
D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis / Q000097:blood; D002004:Brucella Vaccine / Q000276:immunology; D002003:Brucella abortus / Q000276:immunology*; D002006:Brucellosis / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D007113:Immunity, Innate / Q000276:immunology; D008297:Male; D011897:Random Allocation; D012756:Sheep; D012757:Sheep Diseases / Q000276:immunology* / Q000517:prevention & control*
D000907:Antibodies, Bacterial; D002004:Brucella Vaccine